Reply to "Letter to the editor regarding 'Stereotactic radiosurgery for bone metastases in oligometastatic prostate cancer patients: DESTROY-2 clinical trial subanalysis'"

Clin Transl Oncol. 2022 Jun;24(6):1217-1218. doi: 10.1007/s12094-022-02813-y. Epub 2022 Mar 19.
No abstract available

Keywords: Oligometastases; Prostate cancer; Radiosurgery; Stereobody radiotherapy.

Publication types

  • Letter
  • Comment

MeSH terms

  • Bone Neoplasms* / radiotherapy
  • Bone Neoplasms* / secondary
  • Bone Neoplasms* / surgery
  • Humans
  • Male
  • Prostatic Neoplasms* / pathology
  • Prostatic Neoplasms* / radiotherapy
  • Prostatic Neoplasms* / surgery
  • Radiosurgery*